Skip to content

Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment

Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment - ClinicIMPPACT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42524
Enrollment
15
Registered
2015-10-27
Start date
2015-11-23
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal liver metastases

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: • patients admitted for radiofrequency ablation (RFA) of a liver tumor (maximum tumor diameter of 3 cm, max. 3 lesions) • age >= 18 years • written informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria • known anaphylactic reaction against iodine / contrast agent • malfunction of the kidney (non treatable renal insufficiency; MDRD

Design outcomes

Primary

MeasureTime frame
Comparison of the size and shape of the real ablation zone of liver tumors with the simulation results of the ClinicIMPPACT software environment.

Secondary

MeasureTime frame
Evaluation of the workflow steps of the ClinicIMPPACT procedure. Patient outcome (complications, tumor recurrence, survival)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)